How should dermatologists approach conversations about partial vs complete repigmentation for patients on ruxolitinib for vitiligo?

Featuring Amy McMichael, MD | Professor and Chair, Dermatology Wake Forest School of Medicine Winston Salem, NC | Published June 02, 2025